New gel promises Ultra-Fast itch relief in seconds
NCT ID NCT07580911
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a gel made from hyaluronan (HA35) to see if it can quickly relieve moderate-to-severe itching from conditions like eczema, insect bites, and hives. About 30 adults will apply the gel once, and researchers will check itch levels at several time points up to 24 hours. The goal is to find a safe, non-drug option for fast itch relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18-65 years, male or female * Moderate-to-severe skin pruritus (NRS ≥6) due to eczema, neurodermatitis, insect bites, urticaria, or postoperative wound itch * Able to understand and complete NRS assessments independently * Signed written informed consent Exclusion Criteria: * Topical corticosteroid/antihistamine use within 2 weeks * Infected, broken, or exudative skin lesions at the application site * Known hypersensitivity to hyaluronan or gel components * Severe systemic disease or immune dysfunction * Pregnant or lactating women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Eczema itch are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test revolution: pinpointing the cause of swelling attacks
- Can a smartphone app ease the misery of eczema, psoriasis, and hives?
- Scientists launch study to unravel mysterious chronic itch
- AI tool aims to cut allergy misdiagnosis in primary care
- New tablet shows promise for chronic hives in small study
- Ear seeds and allergy pills: a new combo for hives?